This initiative focuses on identifying biochemical markers capable of detecting disease progression before clinical symptoms emerge. Researchers study protein expression changes, metabolic signaling patterns, and molecular instability associated with early pathological states.

Large-scale proteomic analysis and AI-assisted pattern recognition systems help identify predictive biomarker signatures across multiple disease models.

The project aims to support the development of more accurate and earlier diagnostic technologies.